Back
Akero Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
42
AKRO
Akero Therapeutics
Last Price:
$50.35
Seasonality Move:
49.94%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is moderately bearish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.43 | Sell |
20-day SMA: | 54.06 | Sell |
50-day SMA: | 48.44 | Buy |
200-day SMA: | 38.72 | Buy |
8-day EMA: | 52.78 | Sell |
20-day EMA: | 52.69 | Sell |
50-day EMA: | 49.52 | Buy |
200-day EMA: | 40.57 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.98 | Buy |
Relative Strength Index (14 RSI): | 48.22 | Sell |
Chaikin Money Flow: | -102739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.86 - 55.36) | Sell |
Bollinger Bands (100): | (40.13 - 51.99) | Buy |
Akero Therapeutics Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 51.52 while AKRO 8-day simple moving average is 53.43, which is a Sell signal.
-
The stock price of AKRO is 51.52 while Akero Therapeutics 20-day SMA is 54.06, which makes it a Sell.
-
Akero Therapeutics 50-day simple moving average is 48.44 while AKRO share price is 51.52, making it a Buy technically.
-
AKRO stock price is 51.52 and Akero Therapeutics 200-day simple moving average is 38.72, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a SellThe current Akero Therapeutics [AKRO] share price is $51.52. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
4.1B
Price in USD:
51.52
Share Volume:
853.5K
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
21.34
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 51.52 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 51.52 while AKRO 8-day exponential moving average is 52.78, which is a Sell signal.
-
The stock price of AKRO is 51.52 while Akero Therapeutics 20-day EMA is 52.69, which makes it a Sell.
-
Akero Therapeutics 50-day exponential moving average is 49.52 while AKRO share price is 51.52, making it a Buy technically.
-
AKRO stock price is 51.52 and Akero Therapeutics 200-day simple moving average is 40.57, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 0.98, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 48.22, which suggest Akero Therapeutics is oversold
-
The Bollinger Bands (25) for Akero Therapeutics is (51.86 - 55.36), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (40.13 - 51.99), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.